Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IHIvsFTXHETF Comparison

ETF 1
IHI

iShares U.S. Medical Devices ETF

This fund is part of
US Health Care
+1.73%
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
+1.73%

iShares U.S. Medical Devices ETF (IHI) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) belong to the same industry segment: US Health Care. IHI's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, FTXH's top sector exposures are Healthcare  IHI is less expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.6% for FTXH. IHI is down -15.03% year-to-date (YTD) with -$250M in YTD flows. FTXH performs better with 20.86% YTD performance, and +$846M in YTD flows. Run a side-by-side ETF comparison of IHI and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHI vs FTXH performance and flow charts

Performance

-2.00.02.04.0%Jun 29Jul 6Jul 13Jul 20Jul 27

Cumulative Flows

0 M200 M400 M600 M800 MJun 29Jul 6Jul 13Jul 20Jul 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/28/2026
1M3MYTD1Y3Y5Y
Perf.
IHI
FTXH
+4.01%+3.06%
+1.53%+18.72%
-15.03%+20.86%
-13.44%+49.94%
-5.93%+55.38%
-14.44%+59.22%
Flows
IHI
FTXH
-$3M+$836M
-$43M+$838M
-$250M+$846M
-$636M+$849M
-$2.73B+$838M
-$3.68B+$841M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHI
FTXH
+28.02%+18.15%
+20.01%+17.09%
+18.19%+16.60%
+19.61%+16.10%
Max drawdown
IHI
FTXH
-8.56%-4.43%
-26.18%-7.50%
-26.72%-19.32%
-33.07%-19.32%
Max drawdown duration
IHI
FTXH
64d20d
245d99d
538d393d
1784d393d
Trading data

Create an account to view trading data

Join for free
IHI
FTXH
Last sale
7/28/2026 at 1:30 PM
$52.69
$39.69
Previous close
07/28/2026
$51.37
$39.05
Consolidated volume
07/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHI
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/28/2026 at 1:30 PM
Live
Closed
IHI
FTXH
Last price
$52.69
$39.69
1D performance
+2.57%
+1.63%
AuM$3.20 B$889.76 M
E/R0.38%0.6%
Characteristics
IHI
FTXH
Management strategyPassivePassive
ProvideriSharesFirst Trust
BenchmarkDow Jones U.S. Select Medical Equipment IndexNASDAQ US Smart Pharmaceuticals Index
N° of holdings4750
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

IHI
USA
91.35%
Ireland
7.6%
Other
1.04%
FTXH
USA
95.49%
Other
4.51%

Sectors

IHI
Healthcare
99.8%
Other
0.2%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement

Diversification

IHI

Total weight of top 15 holdings out of 15

88.02%
FTXH

Total weight of top 15 holdings out of 15

66.57%

Top 15 holdings

Data as of June 30, 2026
IHI
Abbott Laboratories
16.93%
Intuitive Surgical, Inc.
15.09%
Stryker Corp.
11.64%
Edwards Lifesciences Corp.
4.75%
Becton, Dickinson & Co.
4.63%
GE Healthcare Technologies, Inc.
4.51%
Medtronic Plc
4.40%
ResMed, Inc.
4.38%
IDEXX Laboratories, Inc.
4.27%
DexCom, Inc.
4.02%
Boston Scientific Corp.
3.99%
STERIS Plc (Ireland)
3.20%
Zimmer Biomet Holdings, Inc.
2.58%
Penumbra, Inc.
1.92%
Baxter International, Inc.
1.71%
FTXH
Eli Lilly & Co.
7.74%
AbbVie, Inc.
7.39%
Johnson & Johnson
6.98%
Merck & Co., Inc.
6.92%
Bristol Myers Squibb Co.
6.18%
Biogen, Inc.
3.73%
Viatris, Inc.
3.70%
Cardinal Health, Inc.
3.54%
Vertex Pharmaceuticals, Inc.
3.42%
Amgen, Inc.
3.18%
Pfizer Inc.
2.95%
Gilead Sciences, Inc.
2.89%
United Therapeutics Corp.
2.76%
Regeneron Pharmaceuticals, Inc.
2.73%
Jazz Pharmaceuticals Plc
2.46%
Frequently asked questions about IHI and FTXH

How have the IHI and FTXH ETFs performed in 2026?

As of July 28, 2026, IHI is down -15.03% year-to-date (YTD), while FTXH has returned 20.86%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: IHI or FTXH?

Year-to-date, the IHI ETF saw -$250M in flows, compared to +$846M for FTXH.

Which ETF is more volatile: IHI or FTXH?

Over the past year, IHI had a volatility of 20.01%, while FTXH experienced 17.09%.

Which ETF is bigger: IHI or FTXH?

As of July 28, 2026, IHI holds $3.20 B in assets under management (AUM), while FTXH manages $889.76 M.

What sectors do the IHI and FTXH ETFs invest in?

IHI leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.

What are the top holdings of the IHI ETF and FTXH ETF?

IHI top holdings include Abbott Laboratories, Intuitive Surgical, Inc. and Stryker Corp.. FTXH holds in its top three: Eli Lilly & Co., AbbVie, Inc. and Johnson & Johnson.

Which ETF is more diversified: IHI or FTXH?

IHI holds 47 securities with 88.02% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 66.57%.

Advertisement
Advertisement
Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026